Posted in | News | Business | Petrochemicals

PBF Energy Acquires Delaware City Refinery

PBF Energy Company LLC today announced that its subsidiaries, Delaware City Refining Company LLC and Delaware Pipeline Company LLC, have completed their purchase of the Delaware City refinery in Delaware City, Delaware from Valero Energy Corporation.

The acquired assets include a currently idle 190,000 barrel per day refinery, associated terminal and pipeline, and 218 megawatt power plant complex. The purchase price totaled $220 million, subject to certain adjustments. In addition, PBF will be commencing major maintenance work at the refinery and plans to restart the refinery in the first half of 2011. The terminal assets will continue to operate through this period. Thomas D. O’Malley, PBF’s Chairman, said, “PBF looks forward to being a responsible business partner with the State of Delaware, Governor Markell and his administration, the United Steel Workers, the Building Trades and to providing the community with highly valued industrial jobs. Through the efforts of Governor Markell and his administration, and the USW and the Building Trades, we believe the refinery can be a sustainable part of the Delaware and U.S. economies for years to come.”

“The Delaware City refinery and related assets provide an excellent platform upon which PBF plans to grow while focusing on safe, reliable and environmentally responsible operations.” Mr. O’Malley added, “The Delaware City refinery and related assets provide an excellent platform upon which PBF plans to grow while focusing on safe, reliable and environmentally responsible operations.”

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.